Form 4: Elanco Director Defers Cash Retainer into Stock Units

Elanco Animal Health Inc. director Kapila K. Anand acquired 603.9916 deferred stock units by electing to defer cash retainer fees, increasing her total beneficial ownership to 8,085.358 units.

Summary

• Kapila K. Anand, a Director of Elanco Animal Health Inc. (ELAN), acquired 603.9916 Deferred Stock Units (DSUs) on June 30, 2025.
• The acquisition was a result of Ms. Anand electing to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan.
• Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
• The number of DSUs issued was calculated by dividing the deferred cash compensation by the closing price of Elanco common stock on the grant date, which was $14.28.
• Following this transaction, Ms. Anand beneficially owns a total of 8,085.358 Deferred Stock Units.
• The Deferred Stock Units will be settled in stock upon Ms. Anand's separation of service from the Company's Board of Directors.

Sentiment

Score: 7

Explanation: The sentiment is positive as it indicates a director's commitment and alignment with shareholder interests through increased equity ownership, albeit via deferred compensation. It is a routine transaction and not indicative of significant operational changes.

Positives

• The deferral of cash compensation into stock units aligns the director's financial interests more closely with those of the shareholders, promoting long-term value creation.
• The increase in beneficial ownership of company stock by a director demonstrates confidence in the company's future performance.

Future Outlook

The Deferred Stock Units acquired by the director will be settled in Elanco common stock upon her separation of service from the Company's Board of Directors.

Management Comments

• Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan, with such deferred fees credited to the Elanco Deferred Stock Account under the Plan.
• Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
• The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

Industry Context

This transaction represents a standard practice in corporate governance where directors elect to defer cash compensation into equity, aligning their interests with long-term shareholder value. Such deferral plans are common across various industries for public company board members.

Comparison to Industry Standards

• The practice of deferring director cash fees into equity is a widely accepted corporate governance standard, often seen in companies like Pfizer, Zoetis, and Merck, which also operate in the animal health or broader pharmaceutical sectors.
• This mechanism is designed to align the interests of the board members with the long-term performance of the company's stock, similar to how many S&P 500 companies structure their non-employee director compensation.

Corporate Governance

Related Party Transactions

• The transaction involves a director (Kapila K. Anand) acquiring deferred stock units from the company as part of her compensation, which is a standard related-party transaction for director remuneration.

Stakeholder Impact

• Shareholders: The deferral of cash fees into stock units by a director aligns their interests with shareholders, potentially leading to more shareholder-centric decision-making and long-term value creation.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• The Deferred Stock Units will be settled in Elanco common stock upon Kapila K. Anand's separation of service from the Company's Board of Directors.

Key Dates

Recommendation

Keywords

Elanco, ELAN, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, Stock Ownership, Corporate Governance